Trevena, Inc. (TRVN)
OTCMKTS · Delayed Price · Currency is USD
0.0004
+0.0001 (33.33%)
Sep 11, 2026, 3:58 PM EST
Trevena Market Cap
Trevena has a market cap or net worth of $384 as of September 16, 2026. Its market cap has decreased by -99.84% in one year.
Market Cap
384.00
Enterprise Value
n/a
Revenue
546.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since January 31, 2014, Trevena's market cap has decreased from 167.27M to 384.00, a decrease of -100.00%. That is a compound annual growth rate of -64.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 384.00 | -96.66% |
| Dec 31, 2025 | 11.51K | -99.11% |
| Dec 31, 2024 | 1.30M | -88.18% |
| Dec 29, 2023 | 10.96M | -0.67% |
| Dec 30, 2022 | 11.03M | -88.49% |
| Dec 31, 2021 | 95.83M | -71.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Adynxx | 581.00 |
| GlobeImmune | 575.00 |
| Mera Pharmaceuticals | 537.00 |
| Tetra Bio-Pharma | 516.00 |
| Biora Therapeutics | 442.00 |
| Tengion | 402.00 |
| PharmaRoth Labs | 391.00 |
| Nabriva Therapeutics | 323.00 |